Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Merck
Dow
McKinsey
Mallinckrodt
Citi
Queensland Health
Harvard Business School
Cerilliant
Daiichi Sankyo

Generated: February 21, 2018

DrugPatentWatch Database Preview

Desipramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for desipramine hydrochloride and what is the scope of desipramine hydrochloride patent protection?

Desipramine hydrochloride
is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Actavis Totowa, Amneal Pharms Co, Ani Pharms Inc, Corepharma, Heritage Pharms Inc, Ingenus Pharms Llc, Sandoz, Usl Pharma, and Us Pharm Holdings, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for desipramine hydrochloride. Sixteen suppliers are listed for this compound.
Pharmacology for desipramine hydrochloride
Medical Subject Heading (MeSH) Categories for desipramine hydrochloride

US Patents and Regulatory Information for desipramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 072102-001 Jun 20, 1988 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Usl Pharma DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071864-001 Sep 9, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 072100-001 May 24, 1988 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071803-001 May 29, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ingenus Pharms Llc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 204963-002 Dec 26, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Heritage Pharms Inc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 207433-002 May 5, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-005 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 072101-001 May 24, 1988 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ingenus Pharms Llc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 204963-006 Dec 26, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071601-001 Jun 5, 1987 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for desipramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PERTOFRANE desipramine hydrochloride CAPSULE;ORAL 013621-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PERTOFRANE desipramine hydrochloride CAPSULE;ORAL 013621-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-007 Feb 11, 1982 ➤ Sign Up ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-007 Feb 11, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
UBS
Chinese Patent Office
McKinsey
Express Scripts
US Department of Justice
Fuji
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot